{"id":"NCT00079677","sponsor":"Cephalon","briefTitle":"Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea (OSA/H) Syndrome","officialTitle":"A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of CEP-10953 (150 mg/Day) as Treatment for Adults With Residual Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-03","primaryCompletion":null,"completion":"2004-10","firstPosted":"2004-03-12","resultsPosted":"2010-02-03","lastUpdate":"2013-07-19"},"enrollment":263,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Obstructive Sleep Apnea","Sleep Hypopnea"],"interventions":[{"type":"DRUG","name":"Armodafinil 150 mg/day","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective of this study is to determine whether treatment with Armodafinil (CEP-10953) is more effective than placebo treatment for patients with residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome (OSAHS) by measuring mean sleep latency from the Maintenance of Wakefulness Test (MWT) (30 minute version) (average of 4 naps at 0900, 1100, 1300, and 1500) and by Clinical Global Impression of Change (CGI C) ratings (as related to general condition) at week 12 (or last postbaseline visit).","primaryOutcome":{"measure":"Maintenance of Wakefulness Test (MWT)","timeFrame":"Change from baseline at 12 weeks or early termination","effectByArm":[{"arm":"Armodafinil 150 mg/Day","deltaMin":2.3,"sd":7.8},{"arm":"Placebo","deltaMin":-1.3,"sd":7.08}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0003"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":129},"commonTop":["Headache","Upper respiratory tract infection"]}}